X-ray structural studies and molecular orbital calculations (CNDO/2) in a series of cyclopenta[a]phenanthrenes: attempts at correlation with carcinogenicity. 1983

A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter

Comparative X-ray crystallographic structure analyses have been carried out on seven cyclopenta[a]phenanthrenes, namely 15,16-dihydocyclopenta[a]phenanthren-17-one and its 2-, 6- and 12-methyl homologues (non-carcinogens) and the 7-and 11-methyl and 1,11-methano derivatives (carcinogens). All-valence-electron molecular-orbital calculations by the CNDO/2 method, using the crystallographic parameters, have also been executed. Charge distribution and the energies of the highest occupied molecular orbitals (HOMO) and lowest unoccupied molecular orbitals (LUMO) have been calculated. With one exception all the molecules show only small deviations from planarity, the exception being the strongly carcinogenic 11-methyl-17-ketone in which the bay-region methyl group causes out-of-plane deformation of the benzo rings of 12.5 degrees. Among the other six compounds the two carcinogens are readily differentiated by high angle strain induced by a 7-methyl group or a 1,11-methano bridge. As expected, the HOMO's of these molecules to some extent reflect their ease of chemical oxidation at the 6,7-double bond; biological oxidation is less easy to correlate probably due to spatial restrictions at the active site within the mono-oxygenase.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D006067 Gonanes Steroids containing the fundamental tetracyclic unit with no methyl groups at C-10 and C-13 and with no side chain at C-17. The concept includes both saturated and unsaturated derivatives.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions

Related Publications

A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
April 1973, Cancer research,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
January 1989, Toxicology letters,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
January 1977, Bioinorganic chemistry,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
January 1977, Bioinorganic chemistry,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
October 1973, Journal of the American Chemical Society,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
January 1992, Journal of medicinal chemistry,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
September 1978, Biochimica et biophysica acta,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
March 1977, Biochimica et biophysica acta,
A F Clayton, and M M Coombs, and K Henrick, and M McPartlin, and J Trotter
May 2001, Mutation research,
Copied contents to your clipboard!